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596a Wednesday, February 11, 2015Key Findings: Pargyline increased dialysate 5-HT concentration from 1.85 0.3
at baseline to 3.95 0.5 nM but decreased dialysate 5-HIAA concentration from
20.75 1.0 at baseline to 15.85 1.4 nM at 60-80 min of administration. Fluox-
etine increased dialysate 5-HT concentration from 1.95 0.4 at baseline to 6.55
0.9 nM at 60-80 min of administration, but did not change dialysate 5-HIAA
concentration. Local administration of ADP (100 mM) increased dialysate 5-
HT and 5-HIAA concentrations. Pargyline did not affect ADP-induced increase
in dialysate 5-HT concentration but suppressed ADP-induced increase in dialy-
sate 5-HIAA concentration during 60 min of ADP administration. Fluoxetine
increased dialysate 5-HT concentration at 40-60 min of ADP administration,
but did not affect ADP-induced increase in dialysate 5-HIAA concentration.
Significance: Simultaneous monitoring of myocardial interstitial 5-HT and
5-HIAA levels provides valuable information on 5-HT kinetics including reup-
take and enzymatic degradation by MAO, which play a role in the regulation
of myocardial interstitial 5-HT levels at baseline and when 5-HT levels are
elevated.
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The therapeutic effect of ghrelin has been reported in humans as well as in an-
imal models of chronic heart failure. However, little is known about the thera-
peutic efficacy of ghrelin for the treatment of inherited forms of dilated
cardiomyopathy (DCM). We aim to examine whether ghrelin is beneficial for
the treatment of inherited DCM with a deletion mutation DK210 in the cardiac
troponin T (cTnT) gene using a knock-in mouse model. Ghrelin (150 mg/kg/day)
was administered subcutaneously to the mouse model of inherited DCM.
The therapeutic effects were examined on the basis of survival and myocardial
remodeling. Ghrelin administration prolonged the life span of DCM mice
compared to the saline-treated controls. Echocardiography data showed that
ghrelin reduced left ventricular (LV) end-diastolic dimensions and increased
LV ejection fraction. Moreover, histoanatomical data revealed that ghrelin
decreased the heart-to-body weight ratio, prevented cardiac remodeling and
fibrosis, and markedly decreased the expression of brain natriuretic peptide.
Telemetry recording and heart rate variability analysis showed that ghrelin sup-
pressed the excessive cardiac sympathetic nerve activity (CSNA) and recovered
the cardiac parasympathetic nerve activity. Ghrelin has therapeutic benefits for
the treatment of DCMwith DK210 mutation in cTnT. Importantly, these cardio-
vascular benefits of ghrelin are likely linked to the suppression of CSNA and
recovery of cardiac parasympathetic nerve activity.
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The N-terminal extension (NTE; residues 42-73) of mouse cardiac troponin T
(TnT) desensitizes cardiac myofilaments to Ca2þ by stabilizing thin filaments
in the blocked-state.We arrived at this conclusion using detergent-skinnedmus-
cle from transgenic (TG)mouse hearts that expressed 54%of chimeric TnT (res-
idues 1-73 of mouse cardiac TnT were replaced by residues 1-41 of mouse fast
skeletal TnT). Here, we extended our investigation to include higher dose effects
of the modified TnT on cardiac myofilament function/phenotype using
detergent-skinned fiber studies and echocardiography measurements in two
different TG mouse lines (TG-55 and TG-64 that expressed 55% and 64% of
chimeric TnT, respectively). Both TG-55 and TG-64 mice showed a similar in-
crease in myofilament Ca2þ sensitivity at sarcomere lengths (SL) of 1.9 and 2.3
mm. However, Ca2þ-activated maximal tension increased significantly only in
TG-64 mice at either SL. There was a progressive decrease in the overall heartsize andheart-to-bodyweight ratios in bothTG-55 andTG-64mice. Left ventric-
ular diastolic functional parameters (isovolumic relaxation time and E-wave
deceleration time) showed a graded increase in TG-55 and TG-64 mice; how-
ever, such effects were only significant in TG-64 mice, suggesting impaired
relaxation. Systolic functional parameters (stroke volume, ejection fraction
and fractional shortening) were unaffected in TG-55 mice, but significantly
decreased in TG-64 mice. Thus, higher levels of chimeric TnT (64%) depressed
both diastolic and systolic function significantly in TG-64mice.Wewill discuss
the link between the effects of the modified N-terminus of TnT on cardiac
myofilament function and the resultant pathological remodeling of the heart.
Our findings have pathological relevance because a growing number of
disease-related mutations are found both in and near the NTE of cardiac TnT.
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The primary structure of the H1-helix of troponin T (TnT) varies among different
types of striated muscles. Moreover, these muscles also express different myosin
heavy chain (MHC) isoforms. Recently, we demonstrated that pseudo-phosphor-
ylation of residue 204 (near the H1-helix) of cardiac TnT affected the functional
state of the thin filament differently in fibers that expressed either a- or b-MHC
isoforms (Michael et al., Basic Res Cardiol, 109:442, 2014). In this follow-up
study, we investigated how the isoform-specific function of the H1-helix of car-
diac TnT was influenced by a- and b-MHC isoforms. We generated a mutant
rat cardiac TnT (RfsH1) in which the cardiac H1-helix was replaced by the fast
skeletal H1-helix. Recombinant RfsH1 was reconstituted into detergent-skinned
cardiac muscle fibers from either normal rats (expressing a-MHC) or propylth-
iouracil treated rats (expressing b-MHC). Steady-state and dynamic measure-
ments were carried out at sarcomere length 2.3 mm. Our results demonstrated
that RfsH1 decreased Ca2þ-activated maximal ATPase activity differently in
a-MHC (~33%) and b-MHC (~17%) fibers. Furthermore, RfsH1 decreased ten-
sion cost (~31%) and crossbridge (XB) distortion dynamics (~25%) in a-MHC
but not in b-MHC fibers. Because the above mentioned parameters are indices
of the rate of XB detachment, our results suggest that the interplay between the
RfsH1- and a-MHC-mediated effects on the thin filament modulates XB detach-
ment kinetics. Our findings suggest that the conformational changes in the H1-
helix of TnT are sensitive toMHC isoform-mediated changes in the thin filament.
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We have engineered cardiac TnCs with increased (L48Q) or decreased (D73N)
Ca2þ sensitivity. To express these proteins in the in vivo heart we utilized an
adeno-associated virus serotype 9 (AAV-9). The Ca2þ desensitized D73N
TnC recapitulated a dilated cardiomyopathy phenotype and depressed function
as observed by echocardiography and isolated cardiomyocytes. On the other
hand, AAV-9 containing the Ca2þ sensitized L48Q TnC did not cause any
disease phenotype or arrhythmias commonly associated with increased myofil-
ament Ca2þ sensitivity. In healthy mice, L48Q TnC increased myocyte contrac-
tion and whole heart contractility with improved cardiovascular performance
(increased V02max). Excitingly, L48Q TnC expressing mice were able to pre-
serve higher contractility, ejection fraction, cardiac performance and decreased
death rate even after undergoing trans-aortic constriction or myocardial in-
farction. Additionally, L48Q TnC was able to increase contractility, ejection
fraction and cardiac performance in mice which expressed L48Q TnC after
having a myocardial infarction. In summary, engineered TnCs show potential
to be used as treatment strategies against different cardiomyopathies.
3008-Pos Board B438
Modeling the Response of Cardiac Troponin C to Calcium on the Thin
Filament: Effects of Disease-Related and Post-Translational Modifications
Jalal K. Siddiqui, Bin Liu, Shane D. Walton, Vikram K. Shettigar,
Andrew J. O’Neil, Grace A. Davis, Peeyush Shrivastava, Jonathan P. Davis.
Physiology and Cell Biology, The Ohio State University, Columbus, OH, USA.
Calcium binding to and dissociation from cardiac troponin C (TnC) are essential
steps leading to cardiac muscle contraction/relaxation. It is well documented
that the calcium binding properties of TnC are not constant, but are sensitive to
complex interactions between the additional thin and even thick filament proteins.
There is a growing body of evidence that protein modifications/mutations within
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effects by altering the apparent TnC calcium sensitivity/exchange kinetics. There
are a number of potential mechanisms that could alter the calcium binding proper-
ties of TnC, potentially the most significant being the ability of the regulatory
domain of TnC to bind the switch peptide region of TnI. We have developed a
rather simple mathematical model that can simulate the steady-state and kinetic
calcium binding properties of a wide assortment of disease-related and post-
translational protein modifications in the isolated troponin complex and reconsti-
tuted thin filament. We propose that roughly half of the studied modifications do
not alter any of the intrinsicTnCcalciumbinding constants but rather alter the abil-
ity of TnC to ‘‘find’’ TnI in the presence of calcium. Considering TnI is essentially
tethered toTnCandcannotdiffuse away in the absenceofcalciumand thatTnI also
binds to actin, we suggest that the apparent calcium binding properties of TnC are
highly dependent upon an ‘‘effective concentration’’ of TnI available to bind TnC.
3009-Pos Board B439
The Contribution of Myosin Binding Protein-C and Troponin I Phosphor-
ylation to the b-Adrenergic Acceleration of Left Ventricular Contraction
and Relaxation
Kenneth S. Gresham, Julian E. Stelzer.
Case Western Reserve University, Cleveland, OH, USA.
Activation of the b-adrenergic signaling pathway in the heart leads to an
increased rate of pressure development in early systole and an acceleration of
relaxation in diastole to increase cardiac output. These effects are mediated by
protein kinase A (PKA), which primarily targets myosin binding protein-c
(MyBP-C) and troponin I (TnI) in the sarcomere for phosphorylation. However,
the relative contributions of MyBP-C and TnI phosphorylation to the b-ad-
renergic-mediated increases in ionotropy and lusitropy remains unclear. To
investigate, we used mice expressing non-phosphorylatable TnI (TnIAla2),
non-phosphorylatable MyBP-C (MyBP-C3SA), and mice expressing non-
phosphorylatable TnI and MyBP-C (TnI Ala2/MyBP-C3SA), as well as control
WT mice. Pressure-volume loop analysis was performed to measure early sys-
tolic pressure development and ventricular relaxation at baseline and in response
to dobutamine (ab-agonist) administration.At baseline therewas nodifference in
systolic pressure development between the groups, but the acceleration of
dp/dtmax after dobutamine administration was blunted in MyBP-C3SA and TnI
Ala2/MyBP-C3SAmice (mmHg/s; 14,41451,016 inWT, 12,9215982 in TnIAla2,
7,8305899 in MyBP-C3SA, and 8,80351,001 in TnI Ala2/MyBP-C3SA after
dobutamine; p<0.05). We examined elastance (E) decay from 75% to 25% of
maximal E (T75-25; normalized to cardiac cycle duration) to measure ventricular
relaxation. At baseline there were no differences between the rate of relaxation in
any of the groups; however, after dobutamine administration MyBP-C3SA and
TnI Ala2/MyBP-C3SA showed a significantly longer relaxation time compared
to WT and TnIAla2 (6.850.3% in WT, 6.950.3% in TnIAla2, 8.350.2% in
MyBP-C3SA, and 8.550.4 in TnI Ala2/MyBP-C3SA after dobutamine; p<0.05).
These results show that MyBP-C phosphorylation is necessary to fully accelerate
contraction and relaxation in response to b-adrenergic signaling.
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Increased cardiac myocyte contractility by the beta-adrenergic system is an
important mechanism to elevate cardiac output to meet greater hemodynamic
load and this process is often depressed in failing hearts. While increased
contractility involves augmented myoplasmic calcium transients, the myofila-
ments also adapt to boost the transduction of the calcium signal. Accordingly,
ventricular contractility is tightly correlated with PKA-mediated phosphoryla-
tion of two myofibrillar proteins, cardiac myosin binding protein-C (cMyBP-C)
and cardiac troponin I (cTnI), implicating these two proteins as important trans-
ducers of hemodynamics to the cardiac sarcomere. Consistent with this, we
have previously found that phosphorylation of myofilament proteins by PKA
(a downstream signaling molecule of the beta-adrenergic system) increased
force, slowed force development rates, sped loaded shortening, and increased
power output in rat skinned cardiac myocyte preparations. Here, we sought
to define molecule-specific mechanisms by which PKA-mediated phosphoryla-
tion modulates these contractile properties. Regarding cTnI, the incorporation
of thin filaments with a majority of unphosphorylated cTnI (as observed in
some models of late stage heart failure) decreased isometric force production
at any given activator [Ca2þ] and these changes were reversed by PKA-mediated phosphorylation in skinned cardiac myocytes. In addition, incorpora-
tion of unphosphorylated cTnI sped rates of force development, which suggests
less cooperative thin filament activation and recruitment of non-cycling cross-
bridges into the pool of cycling cross-bridges, a process that would tend to
depress myocyte force and power. Regarding cMyBP-C, PKA treatment of
slow-twitch skeletal muscle fibers caused phosphorylation of MyBP-C (but
not TnI) and yielded faster loaded shortening velocity and an ~30% increase
in power output. These results add novel insight into the molecular specificity
by which the beta-adrenergic system controls myofibrillar contractility and how
attenuation of PKA-induced phosphorylation of cMyBP-C and cTnI may
contribute to ventricular pump failure.
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Enhanced cardiac contractile function due to increased sarcomere length (SL) is,
in part, mediated by a decrease in the radial distance between myosin heads and
actin. The radial disposition of myosin heads relative to actin is modulated by
cardiac myosin binding protein-C (cMyBP-C), suggesting that cMyBP-C con-
tributes to the length-dependent activation (LDA) in the myocardium. However,
the precise role of cMyBP-C in modulating cardiac LDA is unclear. To deter-
mine the impact of cMyBP-C on LDA, we measured isometric force, myo-
filament Ca2þ-sensitivity (pCa50) and length-dependent crossbridge (XB)
contractile dynamics in skinned ventricular muscle fibers isolated from the
hearts of wild-type (WT) and cMyBP-C knockout (KO) mice, at SL’s 1.9mm
or 2.1mm.Our results show thatmaximal forcewas not significantly different be-
tweenKO andWTfibers. pCa50was not significantly different betweenWT and
KO fibers at long SL (5.8250.02 in WT vs. 5.8750.02 in KO), whereas pCa50
was significantly different betweenWT andKOfibers at short SL (5.7150.02 in
WT vs. 5.8050.01 in KO; p<0.05). The rate of force redevelopment (ktr),
measured at submaximal Ca2þ-activation, was significantly accelerated at short
SL in WT fibers (8.7450.43s-1at 1.9mm vs. 5.7150.40s-1at 2.1mm, p<0.05).
Furthermore, the rates of stretch-induced XB relaxation (krel) and XB recruit-
ment (kdf) were accelerated by 32% and 70%, respectively at short SL in WT
fibers. In contrast, ktr was not significantly different between both SL’s in KO
fibers (8.0350.54s-1at 1.9mm vs. 8.9050.37s-1at 2.1mm). Furthermore, KO fi-
bers did not exhibit length-dependent differences in krel and kdf -suggesting that
LDA is severely depressed in KO fibers. Collectively, our data indicate that
cMyBP-C plays a central role in modulating cardiac LDA.
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The troponin complex is a critical molecular switch involved in transducing the
calcium activating signal into contraction. Troponin I (TnI), the inhibitory sub-
unit of the complex, is phosphorylated as a key regulatory mechanism to alter
the calcium regulation of contraction. Recent work identified a novel phosphor-
ylation of TnI at Tyr-26 that is decreased from its normal basal level in heart
failure with unknown functional effects. Similar to the desensitizing TnI Ser-
23/24 phosphorylation, TnI Tyr-26 is located in the unique cardiac TnI N-ter-
minal extension. Employing TnI containing actual phosphate at Tyr-26 and
Tyr-26 phosphomimetics, we demonstrate that TnI Tyr-26 phosphorylation de-
creases thin filament calcium sensitivity and accelerates deactivation. To assess
the functional integration of TnI Ser-23/24 and Tyr-26 phosphorylation, we
generated recombinant TnI with phosphomimetic substitution at all three resi-
dues. Calcium sensitivity measurements demonstrate no additional effect on
calcium binding to troponin C nor calcium sensitive force development of
the triple phosphomimetic TnI. However, the integration of Tyr-26 with Ser-
23/24 pseudo-phosphorylation further accelerated thin filament deactivation.
The kinase responsible for TnI Tyr-26 phosphorylation remains to be eluci-
dated. Considering that the Src kinase recognition sequence (EEXY) is similar
to that surrounding TnI Tyr-26 when Ser-23/24 are phosphorylated (S(p)S(p)
NY), we hypothesize that Ser-23/24 phosphorylation would exhibit signaling
crosstalk to alter the rate of Tyr-26 phosphorylation. Current efforts are
directed towards determining the ability of Ser-23/24 phosphorylation to modu-
late Src-family kinase phosphorylation of Tyr-26. Our findings suggest that TnI
Tyr-26 phosphorylation in isolation functions similarly to Ser-23/24 N-terminal
